#VisualAbstract: Dupilumab Improves Outcomes in COPD with Blood Eosinophil Evidence of Type 2 Inflammation
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. In this cohort study, using generic versus brand-name fluticasone-salmeterol was associated with similar outcomes in chronic obstructive pulmonary disease ...
1. One-quarter of top-performing quintile hospitals were reclassified to a lower performance group when Medicare Advantage beneficiaries were included compared ...
1. The Summary Elixhauser (S-Elixhauser) comorbidity score is internally validated for predicting 30-day and one-year mortality for older adults. 2. ...
1. In this retrospective analysis of mortality data from a number of national databases, the mortality rates from respiratory diseases ...
1. In patients with mild-to-moderate chronic obstructive pulmonary disease (COPD), pulmonary MRI and CT imaging identified disease phenotypes, exercise limitations ...
Originally published by Harvard Health. What Is It? Chronic obstructive pulmonary disease (COPD) refers to a group of disorders that damage ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.